Nestlé divests its Palforzia business
6. September 2023
September 4, 2023 Nestlé announced today that is has divested Palforzia, its peanut allergy treatment business, to Stallergenes Greer, a biopharmaceutical company which specializes in the diagnosis and treatment of … More Nestlé divests its Palforzia business